2018 FDA approvals hit all time high - but average value slips again
Nat Rev Drug Discov
.
2019 Feb;18(2):90.
doi: 10.1038/d41573-019-00004-z.
Authors
Mathias Baedeker
1
,
Michael Ringel
2
,
Ulrik Schulze
3
Affiliations
1
Boston Consulting Group, Boston, München, Germany.
2
Boston Consulting Group, Boston, Boston, MA, USA.
3
Boston Consulting Group, Boston, Zürich, Switzerland. Schulze.Ulrik@bcg.com.
PMID:
30710141
DOI:
10.1038/d41573-019-00004-z
No abstract available
Keywords:
Business; Drug discovery; Therapeutics.
Publication types
News